Pressure BioSciences, Inc. President and CEO, Richard T. Schumacher, Discusses Recent Company Achievements with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast PHOENIX, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire today announced the release of an interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (the...

Everett Jolly, Host of “Stock Day” Welcomes Richard T. Schumacher of Pressure BioSciences Back on the Show to Discuss Significant Debt to Equity Conversions and other Recent Accomplishments PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” and “the Company”) was recently interviewed on Uptick Newswire’s...

Richard T. Schumacher, CEO of Pressure BioSciences, Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast to Discuss Important New Contract from International Bio-Therapeutic Company and Other Recent Achievements PHOENIX, May 10, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure Biosciences, Inc. (OTCQB:PBIO) (“PBI” and “the company”), joined Everett Jolly on the “Stock Day”...

Pressure BioSciences, Inc. CEO, Ric Schumacher, Rejoins “Stock Day”, Very Optimistic About His Company’s Growth and Success in 2018 and Beyond PHOENIX, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Mr. Richard T. Schumacher, CEO and President of Pressure BioSciences, Inc. (OTCQB:PBIO) (the “Company”) returns to the “Stock Day” podcast for the first...

CEO Richard T. Schumacher Discusses Pressure BioScience’s New Sales Team and Novel Products that are Fueling its Progressive Upturn Phoenix, AZ.,, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Richard T. Schumacher, CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) (the “Company”), was recently interviewed on the Uptick Network Stock Day...